Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06577493 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of Phenazopyridine for Pain Following Urodynamics

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Jul 1, 2025 to Nov 24, 2025
    • Study completion date: Jul 1, 2025 to Jul 1, 2026
    • Site details revised
    v4
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 15, 2024 to Dec 17, 2024
    • Site details revised
    v3
  3. Notable Start date: Sep 15, 2024 to Dec 15, 2024v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to determine if taking phenazopyridine (AZO) at the time of urodynamic study testing will decrease pain experienced by patients after undergoing urodynamic testing.
Trial Details
NCT Number NCT06577493
Lead Sponsor University of South Florida
Conditions
(from sponsor)
Pain After Urodynamic Testing
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov